GLP-1 for Weight Loss: How It Works, Benefits, Side Effects & Safety | Dr. Moxit Shah, DM Endocrinology
GLP-1 for Weight Loss: How It Works, Benefits, Side Effects & Safety
Dr. Moxit Shah, DM Endocrinology | Endocrinologist in Ahmedabad
Weight loss is not simply a matter of willpower. Hunger, appetite regulation, insulin resistance, sleep, genetics and other metabolic factors can make long-term weight management difficult. GLP-1-based medicines have changed medical weight management by targeting biological pathways involved in appetite and satiety.
Medicines such as semaglutide and tirzepatide can produce clinically meaningful weight loss in appropriately selected patients when combined with nutrition, physical activity and ongoing medical care. A 2026 review in the New England Journal of Medicine describes GLP-1 receptor agonists and related incretin therapies as important treatments for type 2 diabetes and obesity, with appetite and gastric-emptying effects contributing to weight loss. Read the NEJM review.
What Are GLP-1 Medicines?
GLP-1 stands for glucagon-like peptide-1, a hormone naturally released after eating. It helps regulate appetite, insulin secretion, glucagon and gastric emptying.
GLP-1 receptor agonists mimic some of these effects. Tirzepatide additionally activates the GIP receptor, so it is more accurately described as a dual GIP/GLP-1 receptor agonist.
How Does GLP-1 Help With Weight Loss?
- Reduces appetite: It acts on appetite-regulating pathways and can reduce hunger.
- Increases satiety: Patients may feel comfortably full with smaller portions.
- Slows gastric emptying: Food can remain in the stomach longer, contributing to fullness.
- Reduces food intake: Reduced hunger and increased satiety can make a sustained calorie deficit easier.
- Improves glucose regulation: These medicines can improve blood glucose control in appropriate patients with type 2 diabetes.
Semaglutide vs Tirzepatide for Weight Loss
Semaglutide is a GLP-1 receptor agonist, whereas tirzepatide activates both GIP and GLP-1 receptors. In the SURMOUNT-5 head-to-head trial in adults with obesity without diabetes, mean weight reduction at 72 weeks was 20.2% with tirzepatide and 13.7% with semaglutide. Gastrointestinal adverse effects were the most common adverse events and occurred mainly during dose escalation. Read the trial.
These results are population averages, not a guarantee for an individual patient. The choice between treatments should consider medical history, diabetes status, treatment goals, tolerability, cost, contraindications and other medicines.
For a detailed comparison, read Semaglutide vs Tirzepatide for Weight Loss and Weight Loss Injections in Ahmedabad: Semaglutide vs Tirzepatide.
How Much Weight Can You Lose?
Weight loss varies between individuals. In the STEP 1 trial, semaglutide 2.4 mg plus lifestyle intervention produced a mean weight reduction of 14.9% at 68 weeks compared with 2.4% with placebo. In SURMOUNT-1, mean weight reduction with tirzepatide at 72 weeks ranged from 15.0% to 20.9%, depending on dose. Semaglutide trial and tirzepatide trial.
More recent head-to-head evidence also shows that treatment response differs between medicines and individuals. The goal should be clinically meaningful and sustainable improvement rather than chasing a particular percentage.
Who May Benefit From GLP-1-Based Weight Management?
Weight-loss medication may be considered for appropriately selected adults with obesity or overweight with weight-related health problems, depending on the specific medicine and its approved indication.
- Obesity
- Overweight with weight-related medical conditions
- Type 2 diabetes with excess weight
- Prediabetes
- Hypertension or abnormal cholesterol associated with excess weight
- Obstructive sleep apnea
- Metabolic dysfunction-associated steatotic liver disease
Eligibility should be assessed individually rather than based only on body weight.
Common GLP-1 Side Effects
The most common adverse effects are gastrointestinal and may be more noticeable when treatment is started or the dose is increased.
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Bloating
- Abdominal discomfort or indigestion
- Reduced appetite
Eating smaller meals, eating slowly, maintaining hydration and following the prescribed dose-escalation schedule may improve tolerability. For more practical information, read GLP-1 Side Effects: What to Expect and How to Manage Them.
Why Is Dose Escalation Important?
Many GLP-1-based treatments use gradual dose escalation. This allows the body to adjust and can improve gastrointestinal tolerability. The dose should be increased according to the specific medicine’s prescribing information and your doctor’s treatment plan.
Read more about GLP-1 Dose Escalation: What to Expect With Semaglutide and Tirzepatide.
What Should You Eat While Taking GLP-1 Medicines?
Medication works best as part of a comprehensive weight-management plan. Focus on adequate protein, vegetables, fibre-rich foods, appropriate portions and hydration. Resistance exercise is particularly important during weight loss because preserving muscle mass matters as body weight falls.
For practical dietary guidance, see GLP-1 Diet: What to Eat While Taking Semaglutide or Tirzepatide.
Do You Regain Weight After Stopping GLP-1 Medicines?
Weight management is often a long-term process. Some people regain weight after discontinuing effective pharmacological treatment, particularly if appetite returns and the underlying biological drivers of weight regain are not addressed. Treatment duration and maintenance strategy should therefore be discussed with your doctor rather than stopping medication independently.
Read more: What Happens When You Stop GLP-1 Medicines?
Are GLP-1 Medicines Safe for Everyone?
No medicine is appropriate for everyone. Before treatment, your doctor should review your medical history, current medicines, diabetes status, gastrointestinal history, pregnancy plans and other relevant risk factors. Some specific medicines have important contraindications and warnings.
GLP-1-based medicines are prescription treatments and should not be purchased or used without appropriate medical supervision.
GLP-1 Medicines Are Not a Replacement for Lifestyle Treatment
A successful medical weight-management plan may combine medication with nutrition, physical activity, resistance training, adequate sleep, behavioural strategies and regular follow-up. The medication can reduce appetite and make these lifestyle changes more achievable, but it does not replace them.
Frequently Asked Questions
Can people without diabetes use GLP-1 medicines for weight loss?
Yes. Certain GLP-1-based medicines and related incretin therapies are approved for chronic weight management in eligible people without diabetes. The specific indication depends on the medicine and local regulatory approval.
How quickly does GLP-1 start working?
Appetite changes may occur early, while meaningful weight loss generally develops progressively over weeks and months as treatment is titrated and lifestyle measures are maintained.
Does GLP-1 directly burn fat?
Its major effect is not direct fat burning. By reducing appetite and food intake, GLP-1-based therapy can help create a sustained energy deficit that leads to weight loss.
Can I stop my medicine once I reach my target weight?
Not necessarily. The best maintenance approach varies from person to person. Discuss continuation, dose adjustment or other maintenance strategies with your treating physician.
Bottom Line
GLP-1-based medicines have become an important part of modern medical weight management. Semaglutide and tirzepatide can produce substantial weight loss in appropriately selected patients, but treatment should be individualized and medically supervised. Current evidence supports meaningful effects on body weight, appetite and several metabolic outcomes. Current NEJM review.
Medical Weight Loss in Ahmedabad
Dr. Moxit Shah, DM Endocrinology provides specialist evaluation and management for diabetes, thyroid disorders and Medical Weight Loss at Vishuddha Diabetes, Thyroid, Weight Loss Clinic in Ahmedabad.
Vishuddha Diabetes, Thyroid, Weight Loss Clinic
Elite Magnum, Bhuyangdev Cross Road, Memnagar/Ghatlodia, Ahmedabad
Appointments: +91 99799 92797
This article is for educational purposes and does not replace an individual medical consultation. GLP-1-based medicines should be used only under appropriate medical supervision.
